Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, discusses how UTMC has begun recruiting patients to participate in an NIH study seeking to identify which coronavirus treatments are most effective and deserve more attention in clinical trials.
Read: UTMC begins participation in national coronavirus treatment study
